-
1
-
-
17444377146
-
The urological management of the patient with acquired immunodeficiency syndrome
-
Heyns CF, Fisher M. The urological management of the patient with acquired immunodeficiency syndrome. BJU Int 2005;95:709-716.
-
(2005)
BJU Int.
, vol.95
, pp. 709-716
-
-
Heyns, C.F.1
Fisher, M.2
-
2
-
-
79959747720
-
Indinavir-induced nephrolithiasis three and one-half years after cessation of indinavir therapy
-
Huynh J, Hever A, Tom T, Sim JJ. Indinavir-induced nephrolithiasis three and one-half years after cessation of indinavir therapy. Int Urol Nephrol 2011;43:571-573.
-
(2011)
Int. Urol. Nephrol.
, Issue.43
, pp. 571-573
-
-
Huynh, J.1
Hever, A.2
Tom, T.3
Sim, J.J.4
-
3
-
-
0037408101
-
Time trends in reported prevalence of kidney stones in the United States 1976-1994
-
Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003;63:1817-1823.
-
Kidney Int.
, vol.2003
, Issue.63
, pp. 1817-1823
-
-
Stamatelou, K.K.1
Francis, M.E.2
Jones, C.A.3
-
4
-
-
0037305779
-
The etiology of urolithiasis in HIV infected patiends
-
Nadler RB, Rubenstein JN, Eggener SE, et al. The etiology of urolithiasis in HIV infected patiends. J Urol 2003;169:475-477.
-
(2003)
J. Urol.
, vol.169
, pp. 475-477
-
-
Nadler, R.B.1
Rubenstein, J.N.2
Eggener, S.E.3
-
5
-
-
13744257116
-
Urologic Diseases of America Project. Urologic Diseases of America project: Urolithiasis
-
Pearle MS, Calhoun EA, Curhan GC; Urologic Diseases of America Project. Urologic Diseases of America project: Urolithiasis. J Urol 2005;173:848-857.
-
(2005)
J. Urol.
, vol.173
, pp. 848-857
-
-
Pearle, M.S.1
Calhoun, E.A.2
Curhan, G.C.3
-
6
-
-
0021813989
-
The current role of medical treatment of nephrolithiasis: The impact of improved techniques of stone removal
-
Preminger GM, Peterson R, Peters PC, Pak CY. The current role of medical treatment of nephrolithiasis: The impact of improved techniques of stone removal. J Urol 1985;134:6-10.
-
(1985)
J. Urol.
, vol.134
, pp. 6-10
-
-
Preminger, G.M.1
Peterson, R.2
Peters, P.C.3
Pak, C.Y.4
-
7
-
-
0035730509
-
The urologist and the patient infected with human immunodeficiency virus or with acquired immunodeficiency syndrome
-
Lee LK, Dinneen MD, Ahmad S. The urologist and the patient infected with human immunodeficiency virus or with acquired immunodeficiency syndrome. BJU Int 2001;88:500-510.
-
(2001)
BJU Int.
, vol.88
, pp. 500-510
-
-
Lee, L.K.1
Dinneen, M.D.2
Ahmad, S.3
-
8
-
-
0012938802
-
Recognizing the urologic manifestations of HIV and AIDS
-
Steele BW, Carson CC. Recognizing the urologic manifestations of HIV and AIDS. Contemp Urol 1997;9:39-53.
-
(1997)
Contemp. Urol.
, vol.9
, pp. 39-53
-
-
Steele, B.W.1
Carson, C.C.2
-
9
-
-
0032704120
-
Strategies of antiretroviral therapy in adults
-
Itani S, Bartlett JA. Strategies of antiretroviral therapy in adults. Urol Clin North Am 1999;26:809-820.
-
(1999)
Urol Clin. North Am.
, vol.26
, pp. 809-820
-
-
Itani, S.1
Bartlett, J.A.2
-
11
-
-
0033763935
-
Increased prevalence and analysis of risk factors for indinavir nephrolithiasis
-
Saltel E, Angel JB, Futter NG, et al. Increased prevalence and analysis of risk factors for indinavir nephrolithiasis. J Urol 2000;164:1895-1897.
-
(2000)
J. Urol.
, vol.164
, pp. 1895-1897
-
-
Saltel, E.1
Angel, J.B.2
Futter, N.G.3
-
12
-
-
0030845902
-
Urolithiasis associated with the protease inhibitor indinavir
-
Bruce RG, Munch LC, Hoven AD, et al. Urolithiasis associated with the protease inhibitor indinavir. Urology 1997;50: 513-518.
-
(1997)
Urology
, vol.50
, pp. 513-518
-
-
Bruce, R.G.1
Munch, L.C.2
Hoven, A.D.3
-
13
-
-
0031965337
-
Anuria and acute renal failure resulting from indinavir sulfate induced nephrolithiasis
-
Witte M, Tobon A, Gruenefelder J, et al. Anuria and acute renal failure resulting from indinavir sulfate induced nephrolithiasis. J Urol 1998;159:498-499.
-
(1998)
J. Urol.
, vol.159
, pp. 498-499
-
-
Witte, M.1
Tobon, A.2
Gruenefelder, J.3
-
15
-
-
75149113301
-
Adverse effects of atazanavir Spa
-
Palacios R, González M, Ruiz J, Santos J. [Adverse effects of atazanavir.] (Spa) Enferm Infecc Microbiol Clin 2008; 26(suppl 17):41-44.
-
(2008)
Enferm. Infecc. Microbiol. Clin.
, vol.26
, Issue.SUPPL. 17
, pp. 41-44
-
-
Palacios, R.1
González, M.2
Ruiz, J.3
Santos, J.4
-
18
-
-
33750268789
-
Atazanavir urinary stones in an HIV-infected patient
-
Pacanowski J, Poirier JM, Petit I, et al. Atazanavir urinary stones in an HIV-infected patient. AIDS 2006;20:2131.
-
(2006)
AIDS
, vol.20
, pp. 2131
-
-
Pacanowski, J.1
Poirier, J.M.2
Petit, I.3
-
19
-
-
34347354196
-
Efficacy and safety of TMC125 (etravirine) in treatment experienced HIV-1- infected patients in DUET-2: 24 week results from a randomised, double-blind, placebo-controlled trial
-
Lazzarin A, Campbell T, Clotet B, et al. Efficacy and safety of TMC125 (etravirine) in treatment experienced HIV-1- infected patients in DUET-2: 24 week results from a randomised, double-blind, placebo-controlled trial. Lancet 2007; 370:39-48.
-
(2007)
Lancet
, vol.370
, pp. 39-48
-
-
Lazzarin, A.1
Campbell, T.2
Clotet, B.3
-
20
-
-
0029790554
-
Renal failure after treatment with ritonavir
-
Duong M, Sgro C, Grappin M, et al. Renal failure after treatment with ritonavir. Lancet 1996;348:693.
-
(1996)
Lancet
, vol.348
, pp. 693
-
-
Duong, M.1
Sgro, C.2
Grappin, M.3
-
21
-
-
0030970649
-
Pancreatorenal syndrome associated with combination antiretroviral therapy in HIV infection
-
Stricker RB, Man KM, Bouvier DB, et al. Pancreatorenal syndrome associated with combination antiretroviral therapy in HIV infection. Lancet 1997;349:1745-1746.
-
(1997)
Lancet
, vol.349
, pp. 1745-1746
-
-
Stricker, R.B.1
Man, K.M.2
Bouvier, D.B.3
-
23
-
-
48749104675
-
Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study
-
Young B, Buchacz K, Baker RK, et al. Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study. J Int Assoc Physicians AIDS Care (Chic) 2007;6:178-187.
-
(2007)
J. Int. Assoc. Physicians AIDS Care Chic
, vol.6
, pp. 178-187
-
-
Young, B.1
Buchacz, K.2
Baker, R.K.3
-
28
-
-
49949098273
-
Same patient, new stone composition: Amprenavir urinary stone
-
Feicke A, Rentsch KM, Oertle D, Strebel RT. Same patient, new stone composition: Amprenavir urinary stone. Antivir Ther 2008;13:733-734.
-
(2008)
Antivir. Ther.
, vol.13
, pp. 733-734
-
-
Feicke, A.1
Rentsch, K.M.2
Oertle, D.3
Strebel, R.T.4
-
29
-
-
80051789059
-
Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir
-
Rockwood N, Mandalia S, Bower M, et al. Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir. AIDS 2011;25: 1671-1673.
-
(2011)
AIDS
, Issue.25
, pp. 1671-1673
-
-
Rockwood, N.1
Mandalia, S.2
Bower, M.3
-
30
-
-
0031718856
-
Renal calculi developing de novo in a patient taking saquinavir
-
Green ST, McKendrick MW, Schmid ML, et al. Renal calculi developing de novo in a patient taking saquinavir. Int J STD AIDS 1998;9:555.
-
(1998)
Int. J. STD AIDS
, vol.9
, pp. 555
-
-
Green, S.T.1
McKendrick, M.W.2
Schmid, M.L.3
|